Apg Asset Management N.V. Zai Lab LTD Transaction History

Apg Asset Management N.V.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$30.21 - $48.1 $102,714 - $163,540	3,400 Added 35.32%	13,027 $433,000
Q4 2022 Feb 14, 2023	BUY	$22.28 - $38.71 $40,104 - $69,678	1,800 Added 23.0%	9,627 $296,000
Q2 2022 Aug 12, 2022	SELL	$23.14 - $49.68 $20,826 - $44,712	-900 Reduced 10.31%	7,827 $260,000
Q1 2022 May 12, 2022	SELL	$27.77 - $64.4 $13,885 - $32,200	-500 Reduced 5.42%	8,727 $345,000
Q4 2021 Feb 11, 2022	BUY	$54.9 - $105.21 $27,450 - $52,605	500 Added 5.73%	9,227 $510,000
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $311,115 - $528,510	-2,963 Reduced 25.35%	8,727 $794,000
Q2 2021 Aug 13, 2021	SELL	$125.11 - $180.0 $435,007 - $625,860	-3,477 Reduced 22.92%	11,690 $1.75 Million
Q1 2021 May 14, 2021	SELL	$126.27 - $191.71 $534,500 - $811,508	-4,233 Reduced 21.82%	15,167 $1.72 Million
Q4 2020 Feb 12, 2021	BUY	$81.94 - $135.34 $196,656 - $324,816	2,400 Added 14.12%	19,400 $2.15 Million
Q3 2020 Nov 12, 2020	BUY	$73.3 - $89.48 $190,580 - $232,648	2,600 Added 18.06%	17,000 $1.21 Million
Q2 2020 Aug 14, 2020	BUY	$48.82 - $82.53 $288,038 - $486,927	5,900 Added 69.41%	14,400 $1.05 Million
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $332,350 - $534,650	8,500 New	8,500 $438,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.43B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.